BD Launches Industry First Ready-to-Use Iodine-Based Surgical Irrigation System

25 May 2021 | Tuesday | News

BD Surgiphor™ sterile wound irrigation system delivers simplified sterility and helps hospitals comply with national and international guidelines
BD Surgiphor™ sterile wound irrigation system

BD Surgiphor™ sterile wound irrigation system

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the availability of BD Surgiphor™ Sterile Wound Irrigation System, the first and only ready-to-use aqueous povidone-iodine (PVP-I) irrigation solution that mechanically loosens and removes wound debris.

BD Surgiphor™ is a pre-mixed, pre-labeled, single patient surgical wound irrigation solution. BD Surgiphor™ uses PVP-I, a well-known antiseptic agent, as a preservative within the solution providing a broad-spectrum antimicrobial effect against gram-positive and gram-negative bacteria and yeast to reduce the risk of unwanted microbial growth in the solution after the bottle is opened.3 The preservative provides a 99.99 percent reduction in bacteria within the bottled solution, giving health care professionals the confidence that the product they are using has a one in a million chance of containing a single viable microorganism.3,4,5


"BD Surgiphor provides hospitals with a ready-made solution for wound irrigation, introducing a new tool in the sterile field that is labeled, effective, and easy to use during a procedure," said Kevin Kelly, worldwide president of Surgery for BD. "Many hospitals today are mixing their own irrigation solutions to keep wounds clean. The introduction of BD Surgiphor will bring more simplicity to the sterile field and help meet best practices established by U.S. and global health agencies."

The use of BD Surgiphor™ can help hospitals meet best practices set forth by U.S. health agencies, including the Joint Commission's 2020 national patient safety goals.6

Kelly continued, "The availability of BD Surgiphor™ moves BD Surgery's portfolio beyond the current focus of surgical site skin prep and into intraoperative solutions. As we look ahead, we believe BD is well positioned to continue growing our presence in the surgical setting."

BD Surgiphor™ was acquired by BD from Orthophor, LLC in November 2020 as part of the company's strategy to leverage tuck-in acquisitions to expand category leadership and augment BD's internal R&D programs. Terms of the deal were not disclosed.

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in